MariMed Inc.
MRMD
$0.07
$0.000.14%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 161.51M | 159.93M | 157.23M | 157.06M | 157.89M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 161.51M | 159.93M | 157.23M | 157.06M | 157.89M |
| Cost of Revenue | 103.33M | 101.95M | 97.09M | 96.50M | 96.45M |
| Gross Profit | 58.17M | 57.99M | 60.14M | 60.56M | 61.44M |
| SG&A Expenses | 59.29M | 60.20M | 59.24M | 59.68M | 60.53M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 162.62M | 162.14M | 156.33M | 156.19M | 156.99M |
| Operating Income | -1.12M | -2.21M | 904.00K | 876.00K | 902.00K |
| Income Before Tax | -9.21M | -10.74M | -6.73M | -6.88M | -7.07M |
| Income Tax Expenses | 3.41M | 3.59M | 11.23M | 9.13M | 9.30M |
| Earnings from Continuing Operations | -12.62 | -14.33 | -17.95 | -16.00 | -16.37 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -14.00K | -28.00K | -41.00K | -50.00K | -63.00K |
| Net Income | -12.63M | -14.36M | -18.00M | -16.05M | -16.44M |
| EBIT | -1.12M | -2.21M | 904.00K | 876.00K | 902.00K |
| EBITDA | 11.04M | 9.62M | 12.89M | 12.76M | 12.52M |
| EPS Basic | -0.03 | -0.04 | -0.05 | -0.04 | -0.04 |
| Normalized Basic EPS | -0.01 | -0.02 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.04 | -0.04 | -0.05 | -0.04 | -0.04 |
| Normalized Diluted EPS | -0.01 | -0.02 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 1.58B | 1.56B | 1.55B | 1.53B | 1.52B |
| Average Diluted Shares Outstanding | 1.58B | 1.56B | 1.55B | 1.53B | 1.52B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -0.40% | -0.32% | -0.36% | -0.35% |